Kolon Corporation (002020) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
15 Jul, 2026Executive summary
Consolidated revenue for H1 2024 was KRW 2,949.6 billion, up 3.5% year-over-year, with operating profit at KRW 41.8 billion, down 54.0%, and net profit at KRW 246.2 billion, up 351.9% year-over-year.
The group completed the acquisition of Kolon Deck Composite and issued new bonds and convertible bonds for capital management.
Major business segments include holding, construction, mobility, IT, pharmaceuticals, and bio, with diversified revenue streams.
Financial highlights
H1 2024 consolidated revenue: KRW 2,949.6 billion (+3.5% YoY); operating profit: KRW 41.8 billion (-54.0% YoY); net profit: KRW 246.2 billion (+351.9% YoY).
Gross margin improved due to non-recurring gains, while operating margin declined on higher costs.
Debt-to-equity ratio at 286.6%, improved from 299.2% at year-end 2023.
H1 2024 EPS: KRW 19,217 (basic, common stock).
Outlook and guidance
The group aims to enhance shareholder value through stable dividends and continued investment in core and future growth businesses.
Ongoing focus on portfolio optimization, cost control, and capital structure improvement.
Guidance includes further expansion in construction, mobility, and bio segments, with new product launches and R&D investments.
Latest events from Kolon Corporation
- Revenue up 10.7% YoY, net profit positive, major M&A, and TG-C clinical milestone achieved.002020
Q2 2026 - Operating profit rebounded, but net loss deepened amid restructuring and higher debt.002020
Q4 2025 - Revenue up 2.6% to KRW 6.0T, net profit soars, but operating loss recorded in FY2024.002020
Q4 2024 - Q3 2025 returned to profit on KRW 1.44 trillion sales, with major restructuring and strong liquidity.002020
Q3 2025 - H1 2025 saw stable revenue, improved operating profit, but a swing to net loss amid restructuring.002020
Q2 2025 - Q1 2026 revenue up 7.7% YoY, operating profit surges, but net loss persists amid legal and PF risks.002020
Q1 2026 - Q1 2025 revenue grew 4% with higher operating profit, but net loss persisted amid legal and PF risks.002020
Q1 2025 - Q3 2024 sales up 4.7% YoY, net income surges, but operating profit drops sharply.002020
Q3 2024